| Previous Close | 6.75 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 0.00 - 0.00 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 639 |
| Market Cap | 11.302M |
| Beta (3Y Monthly) | 1.11 |
| PE Ratio (TTM) | 21.97 |
| EPS (TTM) | 0.30 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.32 (19.56%) |
| Ex-Dividend Date | 2018-12-13 |
| 1y Target Est | N/A |
OKLAHOMA CITY , Dec. 6, 2018 /PRNewswire/ -- The Board of Directors of PD-Rx Pharmaceuticals, Inc., a publicly held corporation, (OTC: PDRX) today announced that it has declared a onetime dividend of $2.20 ...
OKLAHOMA CITY, May 7, 2018 /PRNewswire/ -- The Board of Directors of PD-Rx Pharmaceuticals, Inc., a publicly held corporation, (PDRX) today announced that it has declared a one time dividend of $.66 per share payable on May 9, 2018 to shareholders of record at the close of business April 30, 2018. This dividend represents a 9.8% projected annual yield utilizing the April 25, 2018 closing market price of $6.75. PD-Rx offers pharmaceutical and management strategies to the healthcare industry. Our management strategies focus on new products, solid business partners, and the specialized segment of the pharmaceutical industry. As a licensed FDA manufacturer and packager, PD-Rx offers a full spectrum of medications and specialized services.